Retrieve available abstracts of 257 articles: HTML format
Single Articles
June 2025
LINDE C, Packer M, Bauersachs J Great debate: ablation of atrial fibrillation should be performed in patients
with heart failure with reduced ejection fraction.
Eur Heart J. 2025 Jun 10:ehaf182. doi: 10.1093. PubMed
RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient
data analysis.
Eur Heart J. 2025;46:2052-2062. PubMedAbstract available
LI L, Guo J, Feng J, Li T, et al Deficiency of the RNA-binding protein RBMS1 improves myocardial fibrosis and
heart failure.
Eur Heart J. 2025 Jun 5:ehaf370. doi: 10.1093. PubMedAbstract available
HAYNES N, Spatz ES The invisible costs of heart failure: a societal toll.
Eur Heart J. 2025 Jun 3:ehaf223. doi: 10.1093. PubMed
CHASELING GK, Uchmanowicz I, Back M, Miro O, et al Heat extremes and cardiovascular diseases: a scientific statement of the
Association of Cardiovascular Nursing & Allied Professions, Association for Acute
Cardiovascular Care, European Association of Preventive Cardiology, Heart Failure
Association, E
Eur Heart J. 2025 Jun 3:ehaf326. doi: 10.1093. PubMedAbstract available
May 2025
DARVISH M, Shakoor A, Feyz L, Schaap J, et al Heart failure: assessment of the global economic burden.
Eur Heart J. 2025 May 30:ehaf323. doi: 10.1093. PubMedAbstract available
TUAL-CHALOT S, Stellos K Unravelling heart failure cellular signalling heterogeneity with spatial
transcriptomics.
Eur Heart J. 2025 May 30:ehaf311. doi: 10.1093. PubMed
BAUDRY G, Pereira O, Roubille F, Villaceque M, et al Cardiologist follow-up and improved outcomes of heart failure: a French
nationwide cohort.
Eur Heart J. 2025 May 18:ehaf218. doi: 10.1093. PubMedAbstract available
LUND LH Heart failure: the need for cardiologist-guided follow-up to improve outcomes.
Eur Heart J. 2025 May 18:ehaf229. doi: 10.1093. PubMed
CREA F New treatments and biomarkers in heart failure, hypertrophic cardiomyopathy, and
familial hypercholesterolaemia.
Eur Heart J. 2025;46:1777-1780. PubMed
LEE SE, Joo JH, Hwang HS, Chen SF, et al Spatial transcriptional landscape of human heart failure.
Eur Heart J. 2025 May 8:ehaf272. doi: 10.1093. PubMedAbstract available
April 2025
WIGGERS H Fatty acids in heart failure patients: friend or foe?
Eur Heart J. 2025 Apr 25:ehaf247. doi: 10.1093. PubMed
VERBRUGGE FH Natriuretic targets in acute heart failure with volume overload: are we
misguided?
Eur Heart J. 2025 Apr 25:ehaf243. doi: 10.1093. PubMed
MARQUES P, Ferreira JP Obesity, metrics of central adiposity, and prognostic significance in heart
failure with preserved and mildly reduced ejection fraction.
Eur Heart J. 2025 Apr 25:ehaf198. doi: 10.1093. PubMed
IVEY-MIRANDA JB, Rao VS, Cox ZL, Moreno-Villagomez J, et al Natriuretic response prediction equation for use with oral diuretics in heart
failure.
Eur Heart J. 2025 Apr 24:ehaf268. doi: 10.1093. PubMedAbstract available
MALGIE J, Wilde MI, Brunner-La Rocca HP, Emans ME, et al Newly diagnosed heart failure with reduced ejection fraction: timing, sequencing,
and titration of guideline-recommended medical therapy.
Eur Heart J. 2025 Apr 24:ehaf244. doi: 10.1093. PubMedAbstract available
DOCHERTY KF, Shen L, McMurray JJV Advocating for better care of patients with heart failure.
Eur Heart J. 2025 Apr 24:ehaf224. doi: 10.1093. PubMed
CREA F Focus on heart failure: sex-related differences, new light shed on SGLT2i
mechanism of action, and heart failure after myocardial infarction.
Eur Heart J. 2025;46:1457-1461. PubMed
PEDICINO D, Volpe M Weekly Journal Scan: a deep insight into aldosterone antagonism across the heart
failure spectrum.
Eur Heart J. 2025 Apr 15:ehaf233. doi: 10.1093. PubMed
VELTMANN C, Duncker D, Maier LS Management of de novo heart failure with reduced ejection fraction:
guideline-recommended medical therapy comes first.
Eur Heart J. 2025 Apr 9:ehaf157. doi: 10.1093. PubMed
AKIN I, Hamdani N, El-Battrawy I Multimodal approaches for targeted treatment of heart failure.
Eur Heart J. 2025 Apr 9:ehaf156. doi: 10.1093. PubMed
XIONG G Post-capillary pulmonary hypertension in heart failure: addressing statistical
and methodological issues in research.
Eur Heart J. 2025 Apr 8:ehae812. doi: 10.1093. PubMed
FAUVEL C, Lamblin N Post-capillary Pulmonary Hypertension in Heart Failure is associated with higher
mortality and morbidity risk: not just a matter of << hasard >>.
Eur Heart J. 2025 Apr 8:ehae814. doi: 10.1093. PubMed
OSTROMINSKI JW, Hojbjerg Lassen MC, Claggett BL, Miao ZM, et al Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in
cardiovascular or kidney disease.
Eur Heart J. 2025;46:1321-1331. PubMedAbstract available
March 2025
SEN P, Sorop O, Merkus D Increasing heart rate in heart failure with preserved ejection fraction: a
sensible way to go?
Eur Heart J. 2025 Mar 25:ehaf109. doi: 10.1093. PubMed
VAN LOON T, Vernooy K, Lumens J Rate acceleration in heart failure with preserved ejection fraction: towards
different strokes for different folks.
Eur Heart J. 2025 Mar 25:ehaf110. doi: 10.1093. PubMed
SOUZA ACDAH, Troschel AS, Marquardt JP, Hadzic I, et al Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse
cardiovascular outcomes.
Eur Heart J. 2025;46:1112-1123. PubMedAbstract available
CREA F Focus on amyloidosis, peripartum cardiomyopathy, and heart failure prediction by
artificial intelligence applied to ECG.
Eur Heart J. 2025;46:987-990. PubMed
SLIWA K, Jackson A, Viljoen C, Damasceno A, et al Pregnancies in women after peri-partum cardiomyopathy: the global European
Society of Cardiology EuroObservational Research Programme Peri-Partum
Cardiomyopathy Registry.
Eur Heart J. 2025;46:1031-1040. PubMedAbstract available
GONZALEZ-LOPEZ E, Maurer MS, Garcia-Pavia P Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision
medicine.
Eur Heart J. 2025;46:999-1013. PubMedAbstract available
BOHM M, Butler J, Coats A, Lauder L, et al Empagliflozin in resistant hypertension and heart failure with preserved ejection
fraction: the EMPEROR-Preserved trial.
Eur Heart J. 2025 Mar 4:ehae938. doi: 10.1093. PubMedAbstract available
February 2025
LINDBERG F, Savarese G Opportunities and challenges in preventing heart failure: when is risk
modifiable?
Eur Heart J. 2025 Feb 28:ehaf042. doi: 10.1093. PubMed
STORK S Suspected heart failure: a clinical pattern that calls for action.
Eur Heart J. 2025 Feb 25:ehae846. doi: 10.1093. PubMed
ABDELLATIF M, Vasques-Novoa F, Trummer-Herbst V, Durand S, et al Autophagy is required for the therapeutic effects of the NAD+ precursor
nicotinamide in obesity-related heart failure with preserved ejection fraction.
Eur Heart J. 2025 Feb 25:ehaf062. doi: 10.1093. PubMed
DOI S, Reddy YNV, Jensen MD, Smith JR, et al Dapagliflozin and ventilatory control during exercise in heart failure with
preserved ejection fraction: the CAMEO-DAPA trial.
Eur Heart J. 2025 Feb 19:ehaf027. doi: 10.1093. PubMed
FIORETTI F, Nair AP, Anker SD, Borlaug BA, et al Therapeutic left-to-right shunting in heart failure.
Eur Heart J. 2025 Feb 13:ehaf120. doi: 10.1093. PubMedAbstract available
ANDERSON L, Bayes-Genis A, Bodegard J, Mullin K, et al Suspected de novo heart failure in outpatient care: the REVOLUTION HF study.
Eur Heart J. 2025 Feb 12:ehaf034. doi: 10.1093. PubMedAbstract available
LAKHAL-LITTLETON S Anaemia, neurohormonal activation, and myocardial iron depletion in heart
failure: can this vicious circle be broken?
Eur Heart J. 2025 Feb 5:ehae798. doi: 10.1093. PubMed
ANGERMANN CE, Sehner S, Gerhardt LMS, Santos-Gallego CG, et al Anaemia predicts iron homoeostasis dysregulation and modulates the response to
empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE
trial.
Eur Heart J. 2025 Feb 5:ehae917. doi: 10.1093. PubMedAbstract available
January 2025
BUTLER J, Hammonds K, Talha KM, Alhamdow A, et al Incident heart failure and recurrent coronary events following acute myocardial
infarction.
Eur Heart J. 2025 Jan 28:ehae885. doi: 10.1093. PubMedAbstract available
PEIKERT A, Vaduganathan M, Claggett BL, Kulac IJ, et al Near-universal prevalence of central adiposity in heart failure with preserved
ejection fraction: the PARAGON-HF trial.
Eur Heart J. 2025 Jan 28:ehaf057. doi: 10.1093. PubMedAbstract available
MATSUMOTO S, Ohno Y, Noda S, Miyamoto J, et al Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge
repair.
Eur Heart J. 2025 Jan 28:ehae924. doi: 10.1093. PubMedAbstract available
BAUERSACHS J, Zieroth S, de Boer RA The year in cardiovascular medicine 2024: the top 10 papers in heart failure.
Eur Heart J. 2025 Jan 23:ehaf017. doi: 10.1093. PubMed
LIUZZO G, Patrono C Weekly Journal Scan: Have we reached the SUMMIT of incretin treatment of heart
failure with preserved ejection fraction and obesity?
Eur Heart J. 2025 Jan 21:ehaf013. doi: 10.1093. PubMed
GASPERETTI A, Carrick RT, Protonotarios A, Murray B, et al Clinical features and outcomes in carriers of pathogenic desmoplakin variants.
Eur Heart J. 2025;46:362-376. PubMedAbstract available
ANTONIADES C, Chan K Using artificial intelligence to spot heart failure from ECGs: is it prime time?
Eur Heart J. 2025 Jan 15:ehae906. doi: 10.1093. PubMed
DHINGRA LS, Aminorroaya A, Sangha V, Pedroso AF, et al Heart failure risk stratification using artificial intelligence applied to
electrocardiogram images: a multinational study.
Eur Heart J. 2025 Jan 13:ehae914. doi: 10.1093. PubMedAbstract available
WILKINSON C, Bhatty A, Batra G, Aktaa S, et al Definitions of clinical study outcome measures for cardiovascular diseases: the
European Unified Registries for Heart Care Evaluation and Randomized Trials
(EuroHeart).
Eur Heart J. 2025;46:190-214. PubMedAbstract available
December 2024
VAN ESSEN BJ, Emmens JE, Tromp J, Ouwerkerk W, et al Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25
years.
Eur Heart J. 2024 Dec 30:ehae868. doi: 10.1093. PubMedAbstract available
VAN LOON T, Rijks J, van Koll J, Wolffs J, et al Accelerated atrial pacing reduces left-heart filling pressure: a combined
clinical-computational study.
Eur Heart J. 2024;45:4953-4964. PubMedAbstract available
FERREIRA JP, Zannad F, Vasques-Novoa F, Neves JS, et al Anaemia, erythrocytosis, and empagliflozin in heart failure with preserved
ejection fraction: the EMPEROR-Preserved trial.
Eur Heart J. 2024 Dec 6:ehae864. doi: 10.1093. PubMed
CREA F Focus on adult congenital heart disease and on the role of inflammation and
clonal haematopoiesis in heart failure.
Eur Heart J. 2024;45:4773-4776. PubMed
November 2024
AI L, de Freitas Germano J, Huang C, Aniag M, et al Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling
after myocardial infarction: role of PR-364.
Eur Heart J. 2024 Nov 27:ehae782. doi: 10.1093. PubMedAbstract available
OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al Percutaneous vs. surgical revascularization of non-ST-segment elevation
myocardial infarction with multivessel disease: the SWEDEHEART registry.
Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093. PubMedAbstract available
MEYER M Accelerated pacing as a treatment for heart failure with preserved ejection
fraction and atrial fibrillation?
Eur Heart J. 2024 Nov 26:ehae766. doi: 10.1093. PubMed
MAZHAR F, Faucon AL, Fu EL, Szummer KE, et al Systemic inflammation and health outcomes in patients receiving treatment for
atherosclerotic cardiovascular disease.
Eur Heart J. 2024;45:4719-4730. PubMedAbstract available
Correction to: Anthracycline-induced cardiovascular toxicity: validation of the
Heart Failure Association and International Cardio-Oncology Society risk score.
Eur Heart J. 2024 Nov 18:ehae818. doi: 10.1093. PubMed
EL BEZE N, Steg PG Heart failure and revascularization: which method to choose and should we even do
it?
Eur Heart J. 2024 Nov 11:ehae715. doi: 10.1093. PubMed
WANDEL S, Desai AS, Chen CW, McMurray JJV, et al Centrally adjudicated vs. investigator-reported outcomes in randomized heart
failure trials.
Eur Heart J. 2024 Nov 9:ehae753. doi: 10.1093. PubMedAbstract available
CREA F Evolving therapeutic approaches to aortic stenosis, tricuspid regurgitation,
hypertrophic cardiomyopathy, and acute heart failure.
Eur Heart J. 2024;45:4451-4455. PubMed
SEFEROVIC PM, Coats AJS, Filippatos G The ESC Textbook of Heart Failure: breaking the new educational frontier.
Eur Heart J. 2024 Nov 6:ehad897. doi: 10.1093. PubMed
October 2024
PEDICINO D, Vergallo R Weekly Journal Scan: RESHAPing potential treatment indications for functional
mitral regurgitation in heart failure.
Eur Heart J. 2024 Oct 29:ehae727. doi: 10.1093. PubMed
KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a
meta-analysis.
Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093. PubMedAbstract available
TAYLOR J New editor-in-chief for European Society of Cardiology heart failure journals.
Eur Heart J. 2024 Oct 16:ehae644. doi: 10.1093. PubMed
MAACK C, Vilahur G, Ruiz-Meana M, Hausenloy D, et al New COST Action 'EUropean network to tackle METAbolic alterations in HEART
failure' (EU-METAHEART).
Eur Heart J. 2024 Oct 16:ehae457. doi: 10.1093. PubMed
VOLPE M, Galiuto L Weekly Journal Scan: FINEARTS-HF supports the role of aldosterone antagonism in
the management of heart failure with mildly reduced or preserved ejection
fraction.
Eur Heart J. 2024 Oct 11:ehae679. doi: 10.1093. PubMed
CREA F New light shed on the treatment of heart failure and on novel therapeutic
targets.
Eur Heart J. 2024;45:3775-3779. PubMed
ROSENGREN A Loop diuretics in cardiovascular disease: friend or foe?
Eur Heart J. 2024;45:3850-3852. PubMed
September 2024
TALHA KM, Metra M, Butler J Heart failure with preserved ejection fraction: underdiagnosed and undertreated
in patients with tricuspid regurgitation.
Eur Heart J. 2024 Sep 9:ehae544. doi: 10.1093. PubMed
HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093. PubMedAbstract available
August 2024
BHATT AS, Vaduganathan M Implementing Medical Therapy During Worsening Heart Failure.
Eur Heart J. 2024 Aug 31:ehae566. doi: 10.1093. PubMed
TANAKA A, Kida K, Matsue Y, Imai T, et al In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute
heart failure: the PREMIER trial.
Eur Heart J. 2024 Aug 31:ehae561. doi: 10.1093. PubMedAbstract available
PASCUAL-FIGAL D, Nunez J, Perez-Martinez MT, Gonzalez-Juanatey JR, et al Colchicine in acutely decompensated heart failure: the COLICA trial.
Eur Heart J. 2024 Aug 30:ehae538. doi: 10.1093. PubMedAbstract available
TARDIF JC, Ouellette K, Boulet J Colchicine improves outcomes in coronary disease, but will it in heart failure?
Eur Heart J. 2024 Aug 30:ehae612. doi: 10.1093. PubMed
MINISTRINI S, Tirandi A Von Willebrand factor in inflammation and heart failure: beyond thromboembolic
and bleeding risk.
Eur Heart J. 2024 Aug 28:ehae543. doi: 10.1093. PubMed
VON HAEHLING S, Doehner W, Evertz R, Garfias-Veitl T, et al Ferric carboxymaltose and exercise capacity in heart failure with preserved
ejection fraction and iron deficiency: the FAIR-HFpEF trial.
Eur Heart J. 2024 Aug 26:ehae479. doi: 10.1093. PubMedAbstract available
KITTIPIBUL V, Mentz RJ Intravenous iron therapy in heart failure with preserved ejection fraction: how
far have we walked?
Eur Heart J. 2024 Aug 26:ehae490. doi: 10.1093. PubMed
REDDY YNV, Melenovsky V, Asokan AK, Haluzik M, et al Dapagliflozin, peptide YY, and weight loss in heart failure with preserved
ejection fraction.
Eur Heart J. 2024 Aug 21:ehae534. doi: 10.1093. PubMed
MANG G, Chen J, Sun P, Ma R, et al Von Willebrand factor exacerbates heart failure through formation of neutrophil
extracellular traps.
Eur Heart J. 2024 Aug 21:ehae517. doi: 10.1093. PubMedAbstract available
CREA F Hot topics in thromboembolic risk prevention, heart failure monitoring, and
cardiomyopathy risk stratification.
Eur Heart J. 2024;45:2899-2903. PubMed
Correction to: Intravenous iron for heart failure, iron deficiency definitions,
and clinical response: the IRONMAN trial.
Eur Heart J. 2024 Aug 20:ehae243. doi: 10.1093. PubMed
ROSENKRANZ S, Hoeper MM, Maron BA Pulmonary hypertension in heart failure: the good, the bad, and the ugly.
Eur Heart J. 2024 Aug 12:ehae518. doi: 10.1093. PubMed
CREA F Heart failure and ischaemic heart disease: new challenges and opportunities.
Eur Heart J. 2024;45:2681-2685. PubMed
RIVERO-SANTANA B, Saldana-Garcia J, Caro-Codon J, Zamora P, et al Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure
Association and International Cardio-Oncology Society risk score.
Eur Heart J. 2024 Aug 6:ehae496. doi: 10.1093. PubMedAbstract available
July 2024
FAUVEL C, Damy T, Berthelot E, Bauer F, et al Post-capillary pulmonary hypertension in heart failure: impact of current
definition in the PH-HF multicentre study.
Eur Heart J. 2024 Jul 26:ehae467. doi: 10.1093. PubMedAbstract available
OSTROMINSKI JW, Chatur S, Vaduganathan M STEPping down diuretic therapy with semaglutide in obesity-related heart failure
with preserved ejection fraction: decongestion or disease modification?
Eur Heart J. 2024 Jul 26:ehae410. doi: 10.1093. PubMed
CREA F Focus on acute myocardial infarction, sex-related differences in coronary bypass
surgery, inflammation in heart failure, and infective endocarditis in prosthetic
valves.
Eur Heart J. 2024;45:2463-2467. PubMed
STORK S Pulmonary artery pressure-guided heart failure care: the setting matters.
Eur Heart J. 2024 Jul 19:ehae441. doi: 10.1093. PubMed
PEDICINO D, Volpe M Weekly Journal Scan: a 'thousand-mile' journey in obesity-related heart failure
treatment begins with a few STEPs.
Eur Heart J. 2024 Jul 10:ehae427. doi: 10.1093. PubMed
OSTROMINSKI JW, Solomon SD, Vaduganathan M Heart failure with preserved ejection fraction therapy: combining sodium-glucose
co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists.
Eur Heart J. 2024 Jul 10:ehae414. doi: 10.1093. PubMed
ZANNAD F, Ferreira JP Proteomics for understanding progression to heart failure in chronic kidney
disease: promising but still not there.
Eur Heart J. 2024 Jul 9:ehae399. doi: 10.1093. PubMed
CREA F A new classification of iron-deficient heart failure, sex-related differences in
the management of atrial fibrillation and mitral regurgitation, and an update on
the genetics of Brugada syndrome.
Eur Heart J. 2024;45:2267-2270. PubMed
CREA F Innovative therapeutic targets in cardio-oncology and a Great Debate in heart
failure.
Eur Heart J. 2024;45:2171-2174. PubMed
BOROVAC JA Guideline-recommended medical therapy for de novo heart failure with reduced
ejection fraction: be patient waiting for reverse remodelling.
Eur Heart J. 2024 Jul 8:ehae400. doi: 10.1093. PubMed
BECHER N, Metzner A, Toennis T, Kirchhof P, et al Atrial fibrillation burden: a new outcome predictor and therapeutic target.
Eur Heart J. 2024 Jul 2:ehae373. doi: 10.1093. PubMedAbstract available
June 2024
HOLFELD J, Nagele F, Polzl L, Engler C, et al Cardiac shockwave therapy in addition to coronary bypass surgery improves
myocardial function in ischaemic heart failure: the CAST-HF trial.
Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093. PubMedAbstract available
VELTMANN C, Duncker D, Doering M, Gummadi S, et al Therapy duration and improvement of ventricular function in de novo heart
failure: the Heart Failure Optimization study.
Eur Heart J. 2024 Jun 12:ehae334. doi: 10.1093. PubMedAbstract available
FRIDAY JM, Cleland JG, Pellicori P, Wolters M, et al Loop diuretic utilisation with or without heart failure: impact on prognosis.
Eur Heart J. 2024 Jun 7:ehae345. doi: 10.1093. PubMedAbstract available
CREA F Focus on emerging cancer drugs, artificial intelligence applied to imaging, and a
new therapeutic target in heart failure.
Eur Heart J. 2024;45:1959-1962. PubMed
BHAVE S, Rodriguez V, Poterucha T, Mutasa S, et al Deep learning to detect left ventricular structural abnormalities in chest
X-rays.
Eur Heart J. 2024;45:2002-2012. PubMedAbstract available
ABBAS N, Haas JA, Xiao K, Fuchs M, et al Inhibition of miR-21: cardioprotective effects in human failing myocardium ex
vivo.
Eur Heart J. 2024;45:2016-2018. PubMed
Correction to: Epidemiology of heart failure in young adults: a French nationwide
cohort study.
Eur Heart J. 2024 Jun 4:ehae187. doi: 10.1093. PubMed
May 2024
PACKER M, Cleland JGF, Bauersachs J Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure
with reduced ejection fraction.
Eur Heart J. 2024 May 28:ehae300. doi: 10.1093. PubMed
YANO T, Takeda A, Murayama K A hidden cause of middle-aged onset heart failure with preserved ejection
fraction: a GTPBP3 variant.
Eur Heart J. 2024 May 24:ehae309. doi: 10.1093. PubMed
FEINSTEIN MJ Human Immunology of Heart Failure: Deconstructing Inflammatory Risk.
Eur Heart J. 2024 May 21:ehae339. doi: 10.1093. PubMed
SUN J, Yao J, Olen O, Halfvarson J, et al Risk of heart failure in inflammatory bowel disease: a Swedish population-based
study.
Eur Heart J. 2024 May 21:ehae338. doi: 10.1093. PubMedAbstract available
Correction to: Anthracycline therapy induces an early decline of cardiac
contractility with transient edema in low risk patients with breast cancer.
Eur Heart J. 2024;45:1764. PubMed
DUBIN RF, Deo R, Ren Y, Wang J, et al Incident heart failure in chronic kidney disease: proteomics informs biology and
risk stratification.
Eur Heart J. 2024 May 17:ehae288. doi: 10.1093. PubMedAbstract available
AVIERINOS JF, Tribouilloy C, Bursi F, Grigioni F, et al Degenerative mitral regurgitation due to flail leaflet: sex-related differences
in presentation, management, and outcomes.
Eur Heart J. 2024 May 16:ehae265. doi: 10.1093. PubMedAbstract available
SHAH SJ, Sharma K, Borlaug BA, Butler J, et al Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved
Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
Eur Heart J. 2024 May 13:ehae322. doi: 10.1093. PubMedAbstract available
PACKER M, Anker SD, Butler J, Cleland JGF, et al Identification of three mechanistic pathways for iron-deficient heart failure.
Eur Heart J. 2024 May 11:ehae284. doi: 10.1093. PubMedAbstract available
CLEPHAS PRD, Zwartkruis VW, Malgie J, van Gent MWF, et al Pulmonary artery pressure monitoring in chronic heart failure: effects across
clinically relevant subgroups in the MONITOR-HF trial.
Eur Heart J. 2024 May 11:ehae323. doi: 10.1093. PubMedAbstract available
WANG R, Schiattarella GG Tackling metabolic defects in HFpEF.
Eur Heart J. 2024;45:1494-1496. PubMed
April 2024
NGO LTH, Peng Y, Denman R, Yang I, et al Long-term outcomes after hospitalization for atrial fibrillation or flutter.
Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093. PubMedAbstract available
JACKSON AM, Goland S, Farhan HA, Yaseen IF, et al A novel score to predict left ventricular recovery in peripartum cardiomyopathy
derived from the ESC EORP Peripartum Cardiomyopathy Registry.
Eur Heart J. 2024;45:1430-1439. PubMedAbstract available
PALUDAN-MULLER C, Vad OB, Stampe NK, Diederichsen SZ, et al Atrial fibrillation: age at diagnosis, incident cardiovascular events, and
mortality.
Eur Heart J. 2024 Apr 9:ehae216. doi: 10.1093. PubMedAbstract available
CREA F The complex interaction between cancer, ischaemic heart disease, and heart
failure, and a focus on arrhythmias including risk stratification in Brugada
syndrome and leadless pacing.
Eur Heart J. 2024;45:1183-1187. PubMed
RUZIEH M Comparative effectiveness research using claims data: meticulous methods don't
solve old problems.
Eur Heart J. 2024;45:1284. PubMed
WU VC, Yeh JK, Chen SW, Wu CL, et al Syphilis and cardiovascular risk: a Taiwanese registry.
Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093. PubMedAbstract available
March 2024
ALCOCER-GAMBA MA, Alvarez-Sangabriel A, de la Parra-Calderon JA Management of heart failure in Mexico: challenges and opportunities.
Eur Heart J. 2024 Mar 29:ehae059. doi: 10.1093. PubMed
PEDICINO D, Volpe M Weekly journal scan: a hard RAFTing to improve long-term survival in heart
failure with severely reduced ejection fraction.
Eur Heart J. 2024 Mar 28:ehae167. doi: 10.1093. PubMed
WYLD M, Webster AC Myocardial infarction and stroke in patients with kidney failure: can we do
better?
Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093. PubMed
SCHUERMANS A, Vlasschaert C, Nauffal V, Cho SMJ, et al Clonal haematopoiesis of indeterminate potential predicts incident cardiac
arrhythmias.
Eur Heart J. 2024;45:791-805. PubMedAbstract available
CLELAND JGF, Kalra PA, Pellicori P, Graham FJ, et al Intravenous iron for heart failure, iron deficiency definitions, and clinical
response: the IRONMAN trial.
Eur Heart J. 2024 Mar 6:ehae086. doi: 10.1093. PubMedAbstract available
CHAIX MA, Dore A, Mondesert B, Mongeon FP, et al Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic
right ventricular heart failure: the PARACYS-RV trial.
Eur Heart J. 2024 Mar 6:ehad890. doi: 10.1093. PubMed
SAYOUR NV, Paal AM, Ameri P, Meijers WC, et al Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical
evidence.
Eur Heart J. 2024 Mar 5:ehae105. doi: 10.1093. PubMedAbstract available
MURARU D, Badano LP, Hahn RT, Lang RM, et al Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis,
and treatment.
Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093. PubMedAbstract available
Correction to: Conventional heart failure therapy in cardiac ATTR amyloidosis.
Eur Heart J. 2024 Mar 1:ehae140. doi: 10.1093. PubMed
February 2024
ZURKAN D, Pitt B, Edelmann F Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation
in patients with and without heart failure: one more beneficial effect?
Eur Heart J. 2024 Feb 6:ehae040. doi: 10.1093. PubMed
January 2024
BERNARDO MC, Carvalho SS, Moreira I Massive myocardial calcification as an aetiology of heart failure.
Eur Heart J. 2024 Jan 23:ehae009. doi: 10.1093. PubMed
BAUERSACHS J, de Boer RA, Zieroth S The year in cardiovascular medicine 2023: the top 10 papers in heart failure and
cardiomyopathies.
Eur Heart J. 2024 Jan 18:ehad878. doi: 10.1093. PubMed
GALIUTO L, Volpe M A new RNA-interference based strategy is associated with mild beneficial effects
in patients with heart failure due to cardiac amyloidosis.
Eur Heart J. 2024 Jan 18:ehae015. doi: 10.1093. PubMed
DOEHNER W, Akyea RK, Ntaios G The obesity paradigm on outcome in heart failure with reduced ejection fraction.
Eur Heart J. 2024 Jan 18:ehad761. doi: 10.1093. PubMed
BUTT JH, McMurray JJV The obesity paradigm on outcome in heart failure with reduced ejection fraction.
Eur Heart J. 2024 Jan 18:ehad764. doi: 10.1093. PubMed
AHN HJ, An HY, Ryu G, Lim J, et al Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east
Asian cohort study.
Eur Heart J. 2024 Jan 17:ehad869. doi: 10.1093. PubMedAbstract available
PELLICORI P, Hunter D, Ei Khin HH, Cleland JGF, et al How to diagnose and treat venous congestion in heart failure.
Eur Heart J. 2024 Jan 9:ehad883. doi: 10.1093. PubMed
ORAII A, Healey JS, Kowalik K, Pandey AK, et al Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis
of clinical trials.
Eur Heart J. 2024 Jan 9:ehad811. doi: 10.1093. PubMedAbstract available
KAMBIC T, Lavie CJ, Eijsvogels TMH Seeking synergy for novel weight- and glucose-lowering pharmacotherapy and
exercise training in heart failure patients with preserved ejection fraction.
Eur Heart J. 2024 Jan 8:ehad856. doi: 10.1093. PubMed
December 2023
Correction to: Participation in a clinical trial is associated with lower
mortality but not lower risk of HF hospitalization in patients with heart
failure: observations from the ESC EORP Heart Failure Long-Term Registry.
Eur Heart J. 2023 Dec 21:ehad855. doi: 10.1093. PubMed
ABU-OWN H, Webb I, Okonko DO Intravenous iron repletion in heart failure: bridging the gap between symptom
relief and hard clinical outcomes.
Eur Heart J. 2023;44:5092-5094. PubMed
KRAMARENKO D, Walsh R Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications.
Eur Heart J. 2023;44:5074-5076. PubMed
LI XM, Zhu XJ, Jing ZC Reverse cardiac remodelling after balloon atrial septostomy for pulmonary
arterial hypertension and end-stage heart failure.
Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093. PubMed
MULLER FS, Aherrahrou Z, Grasshoff H, Heidorn MW, et al Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Eur Heart J. 2023;44:4935-4949. PubMedAbstract available
MEHRA MR, Castagna F, Butler J The transformative potential of left ventricular assist devices in advanced heart
failure: no more a therapeutic orphan.
Eur Heart J. 2023 Dec 11:ehad555. doi: 10.1093. PubMed
KHAN MS, Usman MS, Van Spall HGC, Greene SJ, et al Endpoint adjudication in cardiovascular clinical trials.
Eur Heart J. 2023;44:4835-4846. PubMedAbstract available
WESTWOOD M, Almeida AG, Barbato E, Delgado V, et al Competency-based cardiac imaging for patient-centred care. A statement of the
European Society of Cardiology (ESC). With the contribution of the European
Association of Cardiovascular Imaging (EACVI), and the support of the Association
of Cardiovascul
Eur Heart J. 2023;44:4771-4780. PubMedAbstract available
November 2023
SCHMITTO JD, Shaw S, Garbade J, Gustafsson F, et al Fully magnetically centrifugal left ventricular assist device and long-term
outcomes: the ELEVATE registry.
Eur Heart J. 2023 Nov 30:ehad658. doi: 10.1093. PubMedAbstract available
Correction to: 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis
and treatment of acute and chronic heart failure: Developed by the task force for
the diagnosis and treatment of acute and chronic heart failure of the European
Society of
Eur Heart J. 2023 Nov 23:ehad613. doi: 10.1093. PubMed
CREA F Fighting the pandemic of heart failure: better utilization of current treatments,
new drugs, and new therapeutic targets.
Eur Heart J. 2023;44:4607-4611. PubMed
TOMII D, Praz F, Windecker S Guideline directed medical therapy in patients with heart failure undergoing
transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093. PubMed
HENRY CM, Oseran AS, Zheng Z, Dong H, et al Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in
the United States.
Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093. PubMedAbstract available
JESSEN N, Mocumbi AO, Sliwa K Heart failure in Africa: challenges of dealing with a heterogeneous syndrome in a
heterogeneous continent.
Eur Heart J. 2023 Nov 9:ehad742. doi: 10.1093. PubMed
WERT L, Falk V, Potapov EV Severe aortic regurgitation after short-term treatment with microaxial left
ventricular assist device in the transaxillary approach.
Eur Heart J. 2023 Nov 9:ehad750. doi: 10.1093. PubMed
KIYUNA LA, Candido DS, Bechara LRG, Jesus ICG, et al 4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer
post-translational modification.
Eur Heart J. 2023 Nov 7:ehad662. doi: 10.1093. PubMedAbstract available
SLUIJTER JPG, Xiao J Post-translational modifications upon mitochondrial dysfunction in heart failure.
Eur Heart J. 2023 Nov 6:ehad710. doi: 10.1093. PubMed
INCIARDI RM, Solomon SD Beyond the rhythm: atrial fibrillation, diastolic dysfunction, and heart failure.
Eur Heart J. 2023 Nov 3:ehad747. doi: 10.1093. PubMed
October 2023
RESTIVO A, Paglianiti DA, D'Amario D Left atrial pressure-assisted acute heart failure management in the cardiac
intensive care unit: a proof-of-concept.
Eur Heart J. 2023 Oct 26:ehad730. doi: 10.1093. PubMed
LIUZZO G, Patrono C Moving a STEP forward in the treatment of patients with obesity and heart failure
with preserved ejection fraction.
Eur Heart J. 2023 Oct 25:ehad674. doi: 10.1093. PubMed
CREA F Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction.
Eur Heart J. 2023;44:4203-4207. PubMed
PANDEY A, Kolkailah AA, Cosentino F, Cannon CP, et al Ertugliflozin and hospitalization for heart failure across the spectrum of
pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.
Eur Heart J. 2023 Oct 21:ehad639. doi: 10.1093. PubMed
DENIAU B, Costanzo MR, Sliwa K, Asakage A, et al Acute heart failure: current pharmacological treatment and perspectives.
Eur Heart J. 2023 Oct 18:ehad617. doi: 10.1093. PubMedAbstract available
PEDICINO D, Volpe M Atrial fibrillation ablation improves outcomes in patients with end-stage heart
failure: is it all gold the glitter in the CASTLE?
Eur Heart J. 2023 Oct 17:ehad675. doi: 10.1093. PubMed
CAI A, Qiu W, Xia S, Zhou Y, et al Sex-specific characteristics and outcomes in hospitalized heart failure with
preserved ejection fraction: the China Cardiovascular Association Database-Heart
Failure Center Registry.
Eur Heart J. 2023 Oct 4:ehad619. doi: 10.1093. PubMed
CREA F Focus on heart failure and cardiomyopathies: new ESC Guidelines and key
meta-analyses.
Eur Heart J. 2023;44:3487-3491. PubMed
September 2023
BORLAUG BA, Schaff HV, Asirvatham SJ, Koepp KE, et al Surgical pericardiotomy to treat heart failure with preserved ejection fraction:
a first clinical study.
Eur Heart J. 2023 Sep 22:ehad620. doi: 10.1093. PubMed
MOHANTY S, La Fazia VM, Natale A The Antwerp score: is this the 'new hope on the horizon'?
Eur Heart J. 2023;44:3336-3338. PubMed
PANDEY AK, Bhatt DL, Pandey A, Marx N, et al Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart
failure with preserved ejection fraction.
Eur Heart J. 2023 Sep 7:ehad389. doi: 10.1093. PubMedAbstract available
CREA F Hot topics in congenital heart disease: tetralogy of Fallot, Ross operation,
immunodeficiency, cardiac arrest, and end-stage heart failure.
Eur Heart J. 2023;44:3201-3204. PubMed
LADOUCEUR M Congenitally corrected transposition of the great arteries: have we shifted the
disease 'trajectory?
Eur Heart J. 2023;44:3292-3294. PubMed
ANGERMANN CE, Ertl G Remote heart failure management guided by pulmonary artery pressure home
monitoring: rewriting the future?
Eur Heart J. 2023 Sep 6:ehad525. doi: 10.1093. PubMed
BROWNELL NK, Fonarow GC Hospitalization for heart failure requires a PROMPT response.
Eur Heart J. 2023 Sep 6:ehad444. doi: 10.1093. PubMed
August 2023
GHAZI L, Yamamoto Y, Fuery M, O'Connor K, et al Electronic health record alerts for management of heart failure with reduced
ejection fraction in hospitalized patients: the PROMPT-AHF trial.
Eur Heart J. 2023 Aug 31:ehad512. doi: 10.1093. PubMedAbstract available
LEONG DP, Joseph P, McMurray JJV, Rouleau J, et al Frailty and outcomes in heart failure patients from high-, middle- and low-Income
countries.
Eur Heart J. 2023 Aug 28:ehad595. doi: 10.1093. PubMedAbstract available
CANNIE DE, Syrris P, Protonotarios A, Bakalakos A, et al Emery-Dreifuss Muscular Dystrophy 1 is associated with high risk of malignant
ventricular arrhythmias and end-stage heart failure.
Eur Heart J. 2023 Aug 28:ehad561. doi: 10.1093. PubMedAbstract available
MCALISTER FA Frailty: A new Vital Sign in Heart Failure Comes of age.
Eur Heart J. 2023 Aug 28:ehad559. doi: 10.1093. PubMed
NASER JA, Lee E, Scott CG, Kennedy AM, et al Prevalence and Incidence of Diastolic Dysfunction in Atrial Fibrillation:
Clinical Implications.
Eur Heart J. 2023 Aug 28:ehad592. doi: 10.1093. PubMedAbstract available
VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair:
The STS/ACC Transcatheter Valve Therapy Registry.
Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093. PubMedAbstract available
MERKELY B, Hatala R, Wranicz JK, Duray G, et al Upgrade of right ventricular pacing to cardiac resynchronisation therapy in heart
failure: a randomised trial.
Eur Heart J. 2023 Aug 26:ehad591. doi: 10.1093. PubMedAbstract available
LINDE C The BUDAPEST trial: a good grade for upgrades in heart failure with reduced
ejection fraction.
Eur Heart J. 2023 Aug 26:ehad588. doi: 10.1093. PubMed
PONIKOWSKI P, Mentz RJ, Hernandez AF, Butler J, et al Efficacy of Ferric carboxymaltose in heart failure with iron deficiency: an
individual patient data meta-analysis.
Eur Heart J. 2023 Aug 26:ehad586. doi: 10.1093. PubMedAbstract available
BUENO H, Packer M Acetazolamide for Acute Heart Failure: Is ADVOR a Riddle Wrapped in a Mystery
Inside an Enigma?
Eur Heart J. 2023 Aug 25:ehad560. doi: 10.1093. PubMed
MEEKERS E, Dauw J, Martens P, Dhont S, et al Renal Function and Decongestion With Acetazolamide in Acute Decompensated Heart
Failure: The ADVOR Trial.
Eur Heart J. 2023 Aug 25:ehad557. doi: 10.1093. PubMedAbstract available
MCDONAGH TA, Metra M, Adamo M, Gardner RS, et al 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of
acute and chronic heart failure.
Eur Heart J. 2023 Aug 25:ehad195. doi: 10.1093. PubMed
WU J, Nadarajah R, Nakao YM, Nakao K, et al Temporal trends of cause-specific mortality after diagnosis of atrial
fibrillation.
Eur Heart J. 2023 Aug 25:ehad571. doi: 10.1093. PubMedAbstract available
BAUERSACHS J, Soltani S Sodium-glucose co-transporter 2 inhibitors and mineralocorticoid receptor
antagonists synergism in heart failure: it takes two to tango.
Eur Heart J. 2023 Aug 23:ehad540. doi: 10.1093. PubMed
BANERJEE M, Maisnam I, Pal R, Mukhopadhyay S, et al Mineralocorticoid receptor antagonists with sodium-glucose co-transporter-2
inhibitors in heart failure: a meta-analysis.
Eur Heart J. 2023 Aug 22:ehad522. doi: 10.1093. PubMedAbstract available
VAN DISSEL AC, Opotowsky AR, Burchill LJ, Aboulhosn J, et al End-stage heart failure in congenitally corrected transposition of the great
arteries: a multicentre study.
Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093. PubMedAbstract available
CREA F Late breaking trials in heart failure.
Eur Heart J. 2023;44:2877-2882. PubMed
MARTENS P, Testani J, Damman K Prevention and treatment of diuretic resistance in acute heart failure: when to
use which combination of diuretics?
Eur Heart J. 2023;44:2978-2981. PubMed
CHENG RK, Cuddy SAM Neurohormonal blockade in transthyretin amyloidosis: perhaps one size does not
fit all?
Eur Heart J. 2023;44:2908-2910. PubMed
BAYES-GENIS A, Pascual-Figal D Making STRONGer the transition phase: personalized GDMT through NT-proBNP
monitoring.
Eur Heart J. 2023;44:2963-2965. PubMed
NADARAJAH R, Nakao YM, Wu J, Gale CP, et al Using routinely collected health record data for the earlier detection of heart
failure with preserved ejection fraction: FIND-HFpEF.
Eur Heart J. 2023 Aug 3:ehad440. doi: 10.1093. PubMed
LIN GM, Tsai KZ, Lavie CJ Waist-to-height ratio for the obesity paradox in heart failure: is it a matter of
fitness?
Eur Heart J. 2023 Aug 2:ehad503. doi: 10.1093. PubMed
ROHDE LE, McMurray JJV REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed.
Eur Heart J. 2023 Aug 1:ehad488. doi: 10.1093. PubMed
July 2023
PEDICINO D, Volpe M New evidence supporting haemodynamics-guided remote management of congestion in
heart failure.
Eur Heart J. 2023 Jul 21:ehad435. doi: 10.1093. PubMed
VERGALLO R, Patrono C Heart failure and socioeconomic status: global differences and inequalities.
Eur Heart J. 2023 Jul 15:ehad410. doi: 10.1093. PubMed
GREENE SJ, Fonarow GC Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved
ejection fraction.
Eur Heart J. 2023 Jul 5:ehad427. doi: 10.1093. PubMed
Corrigendum to: Heart failure, peripheral artery disease, and dapagliflozin: a
patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J. 2023 Jul 3:ehad406. doi: 10.1093. PubMed
June 2023
BERGONTI M, Ascione C, Marcon L, Pambrun T, et al Left ventricular functional recovery after atrial fibrillation catheter ablation
in heart failure: a prediction model.
Eur Heart J. 2023 Jun 30:ehad428. doi: 10.1093. PubMedAbstract available
KOEHLER F, Hindricks G Is telemonitoring for heart failure ready after a journey longer than two
decades?
Eur Heart J. 2023 Jun 27:ehad395. doi: 10.1093. PubMed
WITSCH J, Kasner SE Redefining the role of heart failure in stroke.
Eur Heart J. 2023 Jun 26:ehad360. doi: 10.1093. PubMed
YANG M, Kondo T, Butt JH, Abraham WT, et al Stroke in patients with heart failure and reduced or preserved ejection fraction.
Eur Heart J. 2023 Jun 26:ehad338. doi: 10.1093. PubMedAbstract available
CREA F Challenges and opportunities in the management of acute heart failure and cardiac
amyloidosis.
Eur Heart J. 2023;44:2135-2139. PubMed
ARNOTT C, Neal B Good for your heart and safe for your toes: a patient-level meta-analysis of
DAPA-HF and DELIVER.
Eur Heart J. 2023;44:2184-2186. PubMed
TOLOMEO P, Butt JH, Kondo T, Campo G, et al Importance of cystatin C in estimating glomerular filtration rate: the
PARADIGM-HF trial.
Eur Heart J. 2023;44:2202-2212. PubMedAbstract available
PEDICINO D, Vergallo R Long-lasting effects of transcatheter repair of secondary mitral regurgitation:
the latest lesson from COAPT trial.
Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093. PubMed
JANKOWSKA EA, Ponikowski P Acyl-ghrelin therapy for heart failure: already a novel inotrope or even more?
Eur Heart J. 2023;44:2026-2028. PubMed
CREA F Addressing the pandemic of heart failure: old and new therapeutic opportunities.
Eur Heart J. 2023;44:1961-1964. PubMed
MARTENS P, Verbrugge FH, Dauw J, Nijst P, et al Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR
trial.
Eur Heart J. 2023;44:1995-2005. PubMedAbstract available
MAHMOOD SS, Riedell PA, Feldman S, George G, et al Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell
therapy recipients.
Eur Heart J. 2023;44:2029-2042. PubMedAbstract available
MARTENS P, Yu S, Larive B, Borlaug BA, et al Iron deficiency in pulmonary vascular disease: pathophysiological and clinical
implications.
Eur Heart J. 2023;44:1979-1991. PubMedAbstract available
CAMPBELL RT, Docherty KF Serum bicarbonate and congestion: a potential biomarker for identifying and
guiding management in diuretic resistance?
Eur Heart J. 2023;44:2006-2008. PubMed
MARX N, Muller-Wieland D SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials
towards effectiveness in the real world.
Eur Heart J. 2023 Jun 8:ehad282. doi: 10.1093. PubMed
FU EL, Patorno E, Everett BM, Vaduganathan M, et al Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and
type 2 diabetes: an observational cohort study.
Eur Heart J. 2023 Jun 1:ehad273. doi: 10.1093. PubMedAbstract available
May 2023
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in
heart failure and cardiomyopathies.
Eur Heart J. 2023 May 24:ehad307. doi: 10.1093. PubMed
BUTT JH, Kondo T, Yang M, Jhund PS, et al Heart failure, peripheral artery disease, and dapagliflozin: a patient-level
meta-analysis of DAPA-HF and DELIVER.
Eur Heart J. 2023 May 23:ehad276. doi: 10.1093. PubMedAbstract available
CHATUR S, Vaduganathan M, Claggett B, Vardeny O, et al Dapagliflozin and diuretic utilization in heart failure with mildly reduced or
preserved ejection fraction: the DELIVER trial.
Eur Heart J. 2023 May 23:ehad283. doi: 10.1093. PubMedAbstract available
BORLAUG BA, Testani JM SGLT2 inhibitors and Diuretics in Heart Failure: Clicking Reset on the Renal
Volume Setpoint?
Eur Heart J. 2023 May 23:ehad345. doi: 10.1093. PubMed
ADAMO M, Pagnesi M, Mebazaa A, Davison B, et al NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial.
Eur Heart J. 2023 May 22:ehad335. doi: 10.1093. PubMedAbstract available
IOANNOU A, Massa P, Patel RK, Razvi Y, et al Conventional heart failure therapy in cardiac ATTR amyloidosis.
Eur Heart J. 2023 May 22:ehad347. doi: 10.1093. PubMedAbstract available
SCHOLTE NTB, Gurgoze MT, Aydin D, Theuns DAMJ, et al Telemonitoring for heart failure: a meta-analysis.
Eur Heart J. 2023 May 22:ehad280. doi: 10.1093. PubMedAbstract available
CLEPHAS PRD, Radhoe SP, Boersma E, Gregson J, et al Efficacy of Pulmonary Artery Pressure Monitoring in Patients with Chronic Heart
Failure: A Meta-Analysis of Three Randomized Controlled Trials.
Eur Heart J. 2023 May 21:ehad346. doi: 10.1093. PubMedAbstract available
VADUGANATHAN M, Mentz RJ, Claggett BL, Miao ZM, et al Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection
fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and
PARAGON-HF.
Eur Heart J. 2023 May 21:ehad344. doi: 10.1093. PubMedAbstract available
ERN YEOH S, Osmanska J, Petrie MC, Brooksbank KJM, et al Dapagliflozin versus metolazone in heart failure resistant to loop diuretics.
Eur Heart J. 2023 May 21:ehad341. doi: 10.1093. PubMedAbstract available
DAMMAN K Risk of knowing too much: the tricky case of estimated glomerular filtration rate
and treatment decisions in heart failure.
Eur Heart J. 2023 May 20:ehad284. doi: 10.1093. PubMed
MULLENS W, Schulze PC, Westphal J, Bogoviku J, et al Great debate: in patients with decompensated heart failure, acetazolamide in
addition to loop diuretics is the first choice.
Eur Heart J. 2023 May 19:ehad266. doi: 10.1093. PubMed
Corrigendum to: Reduced lean body mass: a potential modifiable contributor to the
pathophysiology of heart failure.
Eur Heart J. 2023 May 8:ehad272. doi: 10.1093. PubMed
CREA F Heart failure with preserved ejection fraction: innovative diagnostic approaches
and therapeutic targets.
Eur Heart J. 2023;44:1481-1485. PubMed
LEHTONEN J, Uusitalo V, Poyhonen P, Mayranpaa MI, et al Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis.
Eur Heart J. 2023;44:1495-1510. PubMedAbstract available
LEE SY, Chang S, Youn JC Successful management of aortic root thrombosis in a patient with Heartmate 3.
Eur Heart J. 2023;44:1578. PubMed
April 2023
XIN Y, Li J, Li H Combination diuretic therapy in acute heart failure.
Eur Heart J. 2023 Apr 21:ehad189. doi: 10.1093. PubMed
Erratum to: Iron deficiency in heart failure across the spectrum of left
ventricular ejection fraction: dotting the i's.
Eur Heart J. 2023 Apr 20:ehad232. doi: 10.1093. PubMed
JALLOH MB, Granger CB, Fonarow GC, Van Spall HGC, et al Multi-level implementation strategies to improve uptake of evidence-based
therapies in heart failure.
Eur Heart J. 2023 Apr 15:ehad150. doi: 10.1093. PubMed
SHERROD CF, Farr SL, Sauer AJ Overcoming treatment inertia for patients with heart failure: how do we build
systems that move us from rest to motion?
Eur Heart J. 2023 Apr 12:ehad169. doi: 10.1093. PubMed
VAN VELDHUISEN DJ, Bauersachs J Digitalis in heart failure: declining use and ongoing outcome trials.
Eur Heart J. 2023 Apr 8:ehad185. doi: 10.1093. PubMed
CREA F The link among heart failure, chronic kidney disease, and cancer: new light shed
on the complex patient.
Eur Heart J. 2023;44:1099-1102. PubMed
March 2023
LAM CSP, Ho JE Do we need dedicated heart failure with preserved ejection fraction clinics?
Eur Heart J. 2023 Mar 29:ehad172. doi: 10.1093. PubMed
SATO R, von Haehling S Revisiting the obesity paradox in heart failure: what is the best anthropometric
index to gauge obesity?
Eur Heart J. 2023 Mar 22:ehad079. doi: 10.1093. PubMed
BUTT JH, Petrie MC, Jhund PS, Sattar N, et al Anthropometric measures and adverse outcomes in heart failure with reduced
ejection fraction: revisiting the obesity paradox.
Eur Heart J. 2023 Mar 22:ehad083. doi: 10.1093. PubMedAbstract available
PACKER M, Siddiqi TJ, Butler J Drugs that slow the progression of diabetic kidney disease: are renoprotective
effects attenuated in heart failure?
Eur Heart J. 2023 Mar 21:ehad158. doi: 10.1093. PubMed
LIUZZO G, Volpe M TRANSFORM-HF closes the loop on diuretic therapy in heart failure.
Eur Heart J. 2023 Mar 21:ehad124. doi: 10.1093. PubMed
DIAZ-CANESTRO C, Ng HF, Yiu KH, Montero D, et al Reduced lean body mass: a potential modifiable contributor to the pathophysiology
of heart failure.
Eur Heart J. 2023 Mar 16:ehad130. doi: 10.1093. PubMed
VERWERFT J, Soens L, Wynants J, Meysman M, et al Heart failure with preserved ejection fraction: relevance of a dedicated dyspnoea
clinic.
Eur Heart J. 2023 Mar 16:ehad141. doi: 10.1093. PubMedAbstract available
PEDICINO D, Volpe M Improving care for heart failure patients by COACHing clinicians to use
decision-support tools.
Eur Heart J. 2023 Mar 16:ehad097. doi: 10.1093. PubMed
RAO VN, Giczewska A, Chiswell K, Felker GM, et al Long-term outcomes of phenoclusters in severe tricuspid regurgitation.
Eur Heart J. 2023 Mar 16:ehad133. doi: 10.1093. PubMedAbstract available
LUND LH, Hage C, Pironti G, Thorvaldsen T, et al Acyl ghrelin improves cardiac function in heart failure and increases fractional
shortening in cardiomyocytes without calcium mobilization.
Eur Heart J. 2023 Mar 14:ehad100. doi: 10.1093. PubMedAbstract available
TAYLOR RS, Dalal HM, Zwisler AD Cardiac rehabilitation for heart failure: 'Cinderella' or evidence-based pillar
of care?
Eur Heart J. 2023 Mar 11:ehad118. doi: 10.1093. PubMedAbstract available
VERELST FR, Van Craenenbroeck EM, Gevaert AB Iron deficiency in heart failure across the spectrum of left ventricular ejection
fraction: dotting the i's.
Eur Heart J. 2023 Mar 9:ehad131. doi: 10.1093. PubMed
SHEMESH E, Chevli PA, Islam T, German CA, et al Circulating ketone bodies and cardiovascular outcomes: the MESA study.
Eur Heart J. 2023 Mar 6:ehad087. doi: 10.1093. PubMedAbstract available
KAPELIOS CJ, Benson L, Crespo-Leiro MG, Anker SD, et al Participation in a clinical trial is associated with lower mortality but not
lower risk of HF hospitalization in patients with heart failure: observations
from the ESC EORP Heart Failure Long-Term Registry.
Eur Heart J. 2023 Mar 4:ehad109. doi: 10.1093. PubMed
February 2023
VOLPE M, Gallo G, Rubattu S Endocrine functions of the heart: from bench to bedside.
Eur Heart J. 2023;44:643-655. PubMedAbstract available
WOUTERS PC, van de Leur RR, Vessies MB, van Stipdonk AMW, et al Electrocardiogram-based deep learning improves outcome prediction following
cardiac resynchronization therapy.
Eur Heart J. 2023;44:680-692. PubMedAbstract available
January 2023
MARK PB, Carrero JJ, Matsushita K, Sang Y, et al Major cardiovascular events and subsequent risk of kidney failure with
replacement therapy: a CKD Prognosis Consortium study.
Eur Heart J. 2023 Jan 24:ehac825. doi: 10.1093. PubMedAbstract available
December 2022
EL-CHOULI M, Meddis A, Christensen DM, Gerds TA, et al Lifetime risk of comorbidity in patients with simple congenital heart disease: a
Danish nationwide study.
Eur Heart J. 2022 Dec 7:ehac727. doi: 10.1093. PubMedAbstract available
November 2022
SCOTTI A, Coisne A, Taramasso M, Granada JF, et al Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing
Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation.
Eur Heart J. 2022 Nov 29:ehac735. doi: 10.1093. PubMedAbstract available
HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a
Danish Nationwide Registry.
Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093. PubMedAbstract available